Skip to main content
SpringerLink
Log in

Interventional Pericardiology

  • Pericardial Disease (AL Klein, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

The space that exists between the visceral and parietal pericardium has a small amount of fluid under physiologic conditions. The pericardial layers and this fluid in combination have a protective role and also offer fluidity of motion and shock absorbance. The pericardium and the fluid can often be involved in pathologies involving the myocardium or sometimes be independently involved in primary diseases of the pericardium with secondary hemodynamic effects. In physiologic and pathologic conditions, invasion of this space by surgical and percutaneous interventions can provide a unique and precious opportunity to enhance patient management in such situations from a diagnostic and therapeutic aspect. This field of “interventional pericardiology” is the focus of this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Osler W. The principles and practice of medicine. New York: Appleton Co; 1892. p. 1079.

    Google Scholar 

  2. Sosa E, Scanavacca M, d’Avila A, Pilleggi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996;7:531–6.

    Article  CAS  PubMed  Google Scholar 

  3. http://www.clevelandclinicmeded.com/live/courses/2010/Pericardio10/pericardio10.pdf.

  4. Rogers FB. Historical review of pericardial diseases. In: Reddy PS, Leon DF, Shaver JA, editors. Pericardial disease. New York: Raven Press; 1982. p. 3–21.

    Google Scholar 

  5. d’Avila A, Scanavacca M, Sosa E, Ruskin JN, Reddy VY. Pericardial anatomy for the Interventional Electrophysiologist. J Cardiovasc Electrophysiol. 2003;14:422–30.

    Article  PubMed  Google Scholar 

  6. Lachman N, Syed FF, Habib A, et al. Correlative anatomy for the electrophysiologist, Part I: the pericardial space, oblique sinus, transverse sinus. J Cardiovasc Electrophysiol. 2010;21(12):1421–6.

    Article  PubMed  Google Scholar 

  7. Maisch B, Seferovic PM, Ristic AD, et al. Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases. Executive summary. Eur Heart J. 2004;25:587–610.

    Article  PubMed  Google Scholar 

  8. Wong B, Murphy J, Chang DJ, Hassenein K, Dunn M. The risks of pericardiocentesis. Am J Cardiol. 1979;44:1110–4.

    Article  CAS  PubMed  Google Scholar 

  9. Krikorian JG, Hancock EW. Pericardiocentesis. Am J Med. 1978;65:808–14.

    Article  CAS  PubMed  Google Scholar 

  10. Fagan SM, Chan KI. Pericardiocentesis. Blind no more! Chest. 1999;116:275–6.

    Article  CAS  PubMed  Google Scholar 

  11. Tsang T, Freeman W, Sinak L, Seward J. Echocardiographically guided pericardiocentesis: evolution and state-of the-art technique. Mayo Clin Proc. 1998;73:647–52.

    Article  CAS  PubMed  Google Scholar 

  12. Tsang T, Enriquez-Sarano M, Freeman W, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002;77:429–36.

    Article  PubMed  Google Scholar 

  13. Kopecky SL, Callahan JA, Tajik AJ, Seward JB. Percutaneous pericardial catheter drainage: report of 42 consecutive cases. Am J Cardiol. 1986;58:633–5.

    Article  CAS  PubMed  Google Scholar 

  14. Ristic AD, Seferovic PM, Petrovic P, et al. Pericardiocentesis feasibility and safety revisited: improvement with simultaneous right ventricular and puncturing needle contrast injections. J Am Coll Cardiol. 1999;32:516A.

    Google Scholar 

  15. Sagrista-Sauleda J, Angel J, Sanchez A, Permanyer-Miralda G, Soler-Soler J. Effusive-constrictive pericarditis. N Engl J Med. 2004;350(5):469–75.

    Article  CAS  PubMed  Google Scholar 

  16. Sosa E, Scanavacca M, D'Avila A, et al. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia. J Cardiovasc Electrophysiol. 1998;9:229–39.

    Article  CAS  PubMed  Google Scholar 

  17. Sosa E, Scanavacca M. Epicardial mapping and ablation techniques to control ventricular tachycardia. J Cardiovasc Electrophysiol. 2005;16:449–52.

    Article  PubMed  Google Scholar 

  18. D’Avila A, Koruth JS, Dukkipati S, Reddy VY. Epicardial access for the treatment of cardiac arrhythmias. Europace. 2012;14 Suppl 2:ii13–8.

    PubMed  Google Scholar 

  19. Weerasooriya R, Jais P, Sacher F, et al. Utility of the lateral fluoroscopic view for subxiphoid pericardial access. Circ Arrhythm Electrophysiol. 2009;2(4):e15–7.

    Article  PubMed  Google Scholar 

  20. Koruth JS, Aryana A, Dukkipati SR, et al. Unusual complications of percutaneous epicardial access and epicardial mapping and ablation of cardiac arrhythmias. Circ Arrhythm Electrophysiol. 2011;4(6):882–8.

    Article  PubMed  Google Scholar 

  21. Seferovic PM, Ristic AD, Maksimovic R, et al. Initial clinical experience with PerDUCERR: promising new tool in the diagnosis and treatment of pericardial disease. Clin Cardiol. 1999;22(Suppl):I-30–35.

    Article  CAS  Google Scholar 

  22. Scanavacca MI, Venancio AC, Pisani EF, et al. Percutaneous transatrial access to the pericardial space for epicardial mapping and ablation. Circ Arrhythm Electrophysiol. 2011;4:331–6.

    Article  PubMed  Google Scholar 

  23. Waxman S, Pulerwitz TC, Rowe KA, Quist WC, Verrier RL. Preclinical safety testing of percutaneous transatrial access to the normal pericardial space for local cardiac drug delivery and diagnostic sampling. Cathet Cardiovasc Intervent. 2000;49:472–7.

    Article  CAS  Google Scholar 

  24. March KL, Woody M, Mehdi K, Zipes DP, Brantly M, Trapnell BC. Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors. Clin Cardiol. 1999;22(Suppl):I-23–29.

    Article  CAS  Google Scholar 

  25. Ceron L, Manzato M, Mazzaro F, Bellavere F. A new diagnostic and therapeutic approach to pericardial effusion: transbronchial needle aspiration. Chest. 2003;123(5):1753–8.

    Article  PubMed  Google Scholar 

  26. Killu AM, Ebrille E, Asirvatham SJ, et al. Percutaneous epicardial access for mapping and ablation is feasible in patients with prior cardiac surgery, including coronary bypass surgery. Circ Arrhythm Electrophysiol. 2015;8(1):94–101. A recent paper reported on the feasibility of percutaneous epicardial access in patients with prior cardiac surgery, including coronary bypass surgery; however, some complications may occur.

  27. Tschabrunn CM, Haqqani HM, Cooper JM, et al. Percutaneous epicardial ventricular tachycardia ablation after noncoronary cardiac surgery or pericarditis. Heart Rhythm. 2013;10(2):165–9.

    Article  PubMed  Google Scholar 

  28. Brugada J, Berruezo A, Cuesta A, et al. Nonsurgical transthoracic epicardial radiofrequency ablation: an alternative in incessant ventricular tachycardia. J Am Coll Cardiol. 2003;41:2036–43.

    Article  PubMed  Google Scholar 

  29. Schweikert RA, Saliba WI, Tomassoni G, et al. Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations. Circulation. 2003;108:1329–35.

    Article  PubMed  Google Scholar 

  30. Verma A, Marrouche NF, Schweikert RA, et al. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia postmyocardial infarction. J Cardiovasc Electrophysiol. 2005;16:465–71.

    Article  PubMed  Google Scholar 

  31. Di Biase L, Santangeli P, Burkhardt DJ, et al. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012;60:132–41.

    Article  PubMed  Google Scholar 

  32. Tung R, Michowitz Y, Yu R, et al. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy. Heart Rhythm. 2013;10(4):490–8.

    Article  PubMed  Google Scholar 

  33. Sarkozy A, Tokuda M, Tedrow UB, et al. Epicardial ablation of ventricular tachycardia in ischemic heart disease. Circ Arrhythm Electrophysiol. 2013;6(6):1115–22.

    Article  PubMed  Google Scholar 

  34. Martinek M, Stevenson WG, Inada K, Tokuda M, Tedrow UB. QRS characteristics fail to reliably identify ventricular tachycardias that require epicardial ablation in ischemic heart disease. J Cardiovasc Electrophysiol. 2012;23(2):188–93.

    Article  PubMed  Google Scholar 

  35. Swarup V, Morton JB, Arruda M, Wilber D. Ablation of epicardial macro-reentrant ventricular tachycardia associated with idiopathic nonischemic dilated cardiomyopathy by a percutaneous transthoracid approach. J Cardiovasc Electrophysiol. 2002;13:1164–8.

    Article  PubMed  Google Scholar 

  36. Hsia HH, Marchlinski FE. Characterization of the electroanatomic substrate for Monomorphic Ventricular Tachycardia in Patients with Nonischemic Cardiomyopathy. PACE. 2002;25:1114–27.

    Article  PubMed  Google Scholar 

  37. Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation. 2003;108(6):704–10.

    Article  PubMed  Google Scholar 

  38. Cano O, Hutchinson M, Lin D, et al. Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. J Am Coll Cardiol. 2009;54(9):799–808.

    Article  PubMed  Google Scholar 

  39. Soejima K, Stevenson WG, Sapp JL, et al. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004;43:1834–42.

    Article  PubMed  Google Scholar 

  40. Piers SR, Leong DP, van Huls van Taxis CF, et al. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility. Circ Arrhythm Electrophysiol. 2013;6(3):513–21.

    Article  CAS  PubMed  Google Scholar 

  41. Hutchinson MD, Gerstenfeld EP, Desjardins B, et al. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4(1):49–55.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Tokuda M, Tedrow UB, Inada K, et al. Direct comparison of adjacent endocardial and epicardial electrograms: implications for substrate mapping. J Am Heart Assoc. 2013;2(5):e000215.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Oloriz T, Silberbauer J, Maccabelli G, et al. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types. Circ Arrhythm Electrophysiol. 2014;7:414–23.

    Article  PubMed  Google Scholar 

  44. Vallès E, Bazan V, Marchlinski FE. ECG criteria to identify epicardial ventricular tachycardia in nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2010;3(1):63–71.

    Article  PubMed  Google Scholar 

  45. Bogun FM, Desjardins B, Good E, et al. Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol. 2009;53:1138–45.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Andreu D, Ortiz-Pérez JT, Boussy T, et al. Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation. Eur Heart J. 2014;35(20):1316–26.

    Article  PubMed  Google Scholar 

  47. Bala R, Ren JF, Hutchinson MD, et al. Assessing epicardial substrate using intracardiac echocardiography during VT ablation. Circ Arrhythm Electrophysiol. 2011;4:667–73.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Pokushalov E, Romanov A, Turov A, Artyomenko S, Shirokova N, Karaskov A. Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia. Heart Rhythm. 2010;7(10):1406–10.

    Article  PubMed  Google Scholar 

  49. Bai R, Di Biase L, Shivkumar K, et al. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol. 2011;4(4):478–85.

    Article  PubMed  Google Scholar 

  50. Berruezo A, Fernandez-Armenta J, Mont L, et al. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol. 2012;5:111–21.

    Article  PubMed  Google Scholar 

  51. Philips B, Madhavan S, James C, et al. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol. 2012;5:499–505.

    Article  PubMed  Google Scholar 

  52. Bazan V, Bala R, Garcia FC, et al. Twelve-lead ECG features to identify ventricular tachycardia arising from the epicardial right ventricle. Heart Rhythm. 2006;3:1132–9.

  53. Henz BD, do Nascimento TA, Dietrich Cde O, et al. Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathy. J Interv Card Electrophysiol. 2009;26:195–205.

    Article  PubMed  Google Scholar 

  54. Santangeli P, Di Biase L, Lakkireddy D, et al. Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility. Heart Rhythm. 2010;7(8):1036–42.

    Article  PubMed  Google Scholar 

  55. Dukkipati SR, d’Avila A, Soejima K, et al. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4:185–94.

    Article  PubMed  Google Scholar 

  56. Nagashima K, Choi EK, Epstein LM, et al. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8(1):87–93.

    Article  PubMed  Google Scholar 

  57. Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123:1270–9.

    Article  PubMed  Google Scholar 

  58. Scanavacca MI, Sternick EB, Pisani C, et al. Accessory atrioventricular pathways refractory to catheter ablation: role of percutaneous epicardial approach. Circ Arrhythm Electrophysiol. 2015;8(1):128–36. This paper considers the role of the percutaneous epicardial approach as an alternative when conventional endocardial or transvenous epicardial ablation fails in the elimination of the accessory pathway.

    Article  PubMed  Google Scholar 

  59. Maisch B, Rupp H, Ristic A, Pankuweit S. Pericardioscopy and epi- and pericardial biopsy - a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy. Heart Fail Rev. 2013;18(3):317–28.

    Article  PubMed  Google Scholar 

  60. Andrade-Alegre R. Pericardioscopy for diagnosing penetrating cardiac trauma. Ann Thorac Surg. 2015;99(5):e115–6. A recent paper that reviews the role of pericardioscopy for diagnosing penetrating cardiac trauma.

    Article  PubMed  Google Scholar 

  61. Ramer S, Sapp JL. Percutaneous intrapericardial injection of triamcinolone in a patient with incessant pericarditis: a novel technique. Can J Cardiol. 2013;29:751.e1.

    Google Scholar 

  62. Frasiolas JA, Cahoon WD. Intrapericardial triamcinolone administration for autoreactive pericarditis. Ann Pharmacother. 2010;44:1641–6.

    Article  CAS  PubMed  Google Scholar 

  63. Maxwell CB, Crouch MA. Intrapericardial triamcinolone for acute pericarditis after electrophysiologic procedures. Am J Health Syst Pharm. 2010;67:269–73.

    Article  CAS  PubMed  Google Scholar 

  64. Dyrda K, Piers SR, van Huls van Taxis CF, Schalij MJ, Zeppenfeld K. Influence of steroid therapy on the incidence of pericarditis and atrial fibrillation after percutaneous epicardial mapping and ablation for ventricular tachycardia. Circ Arrhythm Electrophysiol. 2014;4:671–6.

    Article  Google Scholar 

  65. d'Avila A, Neuzil P, Thiagalingam A, et al. Experimental efficacy of pericardial instillation of anti-inflammatory agents during percutaneous epicardial catheter ablation to prevent postprocedure pericarditis. J Cardiovasc Electrophysiol. 2007;18:1178–83.

    Article  PubMed  Google Scholar 

  66. Lestuzzi C, Berretta M, Tomkowski W. 2015 update on the diagnosis and management of neoplastic pericardial disease. Expert Rev Cardiovasc Ther. 2015;13:377–89. This paper examines updates on new diagnostic techniques and the management of neoplastic pericardial disease.

    Article  CAS  PubMed  Google Scholar 

  67. Shepherd FA, Ginsberg JS, Evans WK, Scott JG, Oleksiuk F. Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol. 1985;3:1678–82.

    CAS  PubMed  Google Scholar 

  68. van Brakel TJ, Hermans JJ, Accord RE, et al. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20(2):207–15.

    Article  PubMed  Google Scholar 

  69. Richardson ES, Rolfes C, Woo OS, Elmquist WF, Benditt DG, Iaizzo PA. Cardiac responses to the intrapericardial delivery of metoprolol: targeted delivery compared to intravenous administration. J Cardiovasc Transl Res. 2012;5(4):535–40.

    Article  PubMed  Google Scholar 

  70. Marcano J, Campos K, Rodriguez V, Handy K, Brewer MA, Cohn WE. Intrapericardial delivery of amiodarone rapidly achieves therapeutic levels in the atrium. Heart Surg Forum. 2013;16(5):E279–86.

    Article  PubMed  Google Scholar 

  71. John RM, Morgan K, Brennecke LH, Benser ME, Jais P. Acute and Chronic Performance Evaluation of a Novel Epicardial Pacing Lead Placed by Percutaneous Subxiphoid Approach in a Canine Model. Circ Arrhythm Electrophysiol. 2015;8(3):659–66.

    Article  PubMed  Google Scholar 

  72. Chatterjee S, Herrmann HC, Wilensky RL, et al. Safety and procedural success of left atrial appendage exclusion with the Lariat Device: a systematic review of published reports and analytic review of the FDA MAUDE Database. JAMA Intern Med. 2015;175(7):1104–9.

    Article  PubMed  Google Scholar 

  73. Varosy PD. Lariat-Small Step or Giant Leap? JAMA Intern Med. 2015;175(7):1110–1.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic, Desk J2-2, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Mandeep Bhargava, Oussama M. Wazni & Walid I. Saliba

  2. Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Mandeep Bhargava & Oussama M. Wazni

Authors
  1. Mandeep Bhargava
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oussama M. Wazni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Walid I. Saliba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mandeep Bhargava.

Ethics declarations

Conflict of Interest

Mandeep Bhargava, Oussama M. Wazni, and Walid I. Saliba declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This manuscript is a review of existing literature on pericardial interventions. It does not directly report on the results of research conducted on any animals or human subjects by the authors primarily for this manuscript. However, the manuscript does reference many articles which have involved human or animal subjects by these authors and other authors in this field and these manuscripts have been published in peer review journals and it is presumed that due diligence has been observed by each of those authors prior to the results being published in the respective journals.

Additional information

This article is part of the Topical Collection on Pericardial Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhargava, M., Wazni, O.M. & Saliba, W.I. Interventional Pericardiology. Curr Cardiol Rep 18, 31 (2016). https://doi.org/10.1007/s11886-016-0698-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-016-0698-9

Keywords

Search

Navigation